P001
|
|
P002
|
Antifungal drug penetration in infected human body fluids and tissues
Poster flash presentation
SSI
A. Cancela Costa
Speaker
Infectious Diseases Service and Microbiology Institute of Lausanne University Hospital (CHUV)E. Glampedakis Infectious Diseases Service and Microbiology Institute of Lausanne University Hospital (CHUV)A. Kritikos Infectious Diseases Service and Microbiology Institute of Lausanne University Hospital (CHUV)F. Grass University Hospital of Lausanne (CHUV)E. Uldry University Hospital of Lausanne (CHUV)C. Delabays University Hospital of Lausanne (CHUV)J. Perentes University Hospital of Lausanne (CHUV)J. Pagani University Hospital of Lausanne (CHUV)B. Guery Infectious Diseases Service and Microbiology Institute of Lausanne University Hospital (CHUV)J. Da Silva Pereira Clara University Hospital of Lausanne (CHUV)L. Decosterd University Hospital of Lausanne (CHUV)F. Lamoth Infectious Diseases Service and Microbiology Institute of Lausanne University Hospital (CHUV)
|
P003
|
HIV-1 drug resistance in patients failing dolutegravir-based regimens: Collaborative analysis of HIV cohort studies
Poster flash presentation
SSI
T. Loosli
Speaker
University and University Hospital of ZurichS. Hossmann University of BernS. Ingle University of BristolK. Kusejko University Hospital of ZurichA. van Sighem Stichting HIV MonitoringM. Stecher German Center for Infection Research (DZIF), Partner-Site Cologne-BonnA. d'Arminio Monforte Italian Cohort Naive Antiretrovirals, (ICONA) L'Azienda Socio Sanitaria Territoriale (ASST) Santi Paolo e CarloJ. Gill University of CalgaryG. Maartens University of Cape TownH. Günthard University and University Hospital of ZurichJ. Sterne University of BristolR. Lessells University of KwaZulu-NatalM. Egger University of BernR. Kouyos
Speaker
University and University Hospital of Zurich
|
P004
|
|
P005
|
Risk and severity of SARS-CoV-2 (re)-infection during the Delta and Omicron waves according to baseline immune status and booster vaccination – a prospective multicentre cohort of health professionals in Switzerland
Poster flash presentation
SSI
B. Babouee Flury Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen S. Güsewell Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen T. Egger Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen O. Leal Epitrack, Recife, BrazilA. Brucher Psychiatry Services of the Canton of St. Gallen (South)E. Lemmenmeier Clienia Littenheid AGD. Meier Kleeb Division of Occupational Health, Kantonal Spital BadenJ. Möller Center for Neurological Rehabilitation ZihlschlachtP. Rieder Hirslanden Clinic ZurichM. Ruetti Fuerstenland Toggenburg Hospital Group, Wil, SwitzerlandH. Schmid Central Laboratory, Kantonsspital BadenR. Stocker Hirslanden Clinic ZurichD. Vuichard-Gysin Infectious Diseases and Hospital Epidemiology, Thurgau Hospital Group, Muensterlingen and Frauenfeld, SwitzerlandB. Wiggli Department of Infectious Diseases and Hospital Epidemiology, Kantonsspital BadenU. Besold Geriatric Clinic St. GallenA. McGeer Sinai Health System, Toronto, CanadaL. Risch Labormedizinisches Zentrum Dr Risch Ostschweiz AGA. Friedl Department of Infectious Diseases and Hospital Epidemiology, Kantonsspital BadenM. Schlegel Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen P. Vernazza Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen S. Kuster Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen C. Kahlert Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen P. Kohler
Speaker
Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen
|
P006
|
|
P007
|
|
P008
|
|
P009
|
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients
Poster flash presentation
SSI
T. PHAM
Speaker
Geneva University Hospitals (HUG)D. Andrey Geneva University Hospitals (HUG)S. Susanne Basel University HospitalB. Sara H. Zurich University HospitalC. Hirzel Inselspital - Universitätsspital BernJ. Tschopp CHUV - University HospitalK. Ullrich Basel University HospitalC. Strahm Kantonspital St GallenP. Schreiber Zurich University HospitalN. Boillat-Blanco CHUV - University HospitalC. Garzoni Clinica luganeseN. Khanna Basel University HospitalO. Manuel CHUV - University HospitalN. Mueller Zurich University HospitalD. Suva Geneva University Hospitals (HUG)C. van Delden Geneva University Hospitals (HUG)I. Uçkay Balgrist University Hospital, University of ZürichD. Neofytos Geneva University Hospitals (HUG)
|
P010
|
Rapid increase of myeloid-derived suppressor cells and prolonged innate immune dysfunctions in patients with COVID-19
Poster flash presentation
SSI
I. Schrijver CHUV Centre Hospitalier Universitaire Vaudois (CHUV)C. Théroude CHUV Centre Hospitalier Universitaire Vaudois (CHUV)C. Gilbert
Speaker
CHUV Centre Hospitalier Universitaire Vaudois (CHUV)N. Antonakos CHUV Centre Hospitalier Universitaire Vaudois (CHUV)D. Le Roy CHUV Centre Hospitalier Universitaire Vaudois (CHUV)P. Bart CHUV Centre Hospitalier Universitaire Vaudois (CHUV)J. Chiche CHUV Centre Hospitalier Universitaire Vaudois (CHUV)M. Perreau CHUV Centre Hospitalier Universitaire Vaudois (CHUV)G. Pantaleo CHUV Centre Hospitalier Universitaire Vaudois (CHUV)T. Calandra CHUV Centre Hospitalier Universitaire Vaudois (CHUV)T. Roger CHUV Centre Hospitalier Universitaire Vaudois (CHUV)
|
P011
|
|
P012
|
Nanopore selective sequencing of pathogens in clinical samples: Application to SARS-CoV-2 genome sequencing
Poster flash presentation
SSI
M. Terrazos Miani Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandL. Borcard Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandS. Gempeler Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandC. Baumann Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandP. Bittel Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandF. Suter-Riniker Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandS. Leib Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandS. Neuenschwander Institute for Infectious Diseases, University of Bern, Bern, SwitzerlandA. Ramette
Speaker
Institute for Infectious Diseases, University of Bern, Bern, Switzerland
|
P013
|
|
P014
|
|
P015
|
|
P016
|
|
P017
|
All-cause mortality in residents from long-care-facilities 2020, 2021 compared to pre-pandemic year 2019: data from a multicentre cohort from Eastern and Western Switzerland
Poster flash presentation
SSHH
G. Scanferla Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen D. Héquet Unité cantonale hygiène, prévention et contrôle de l’infection, Canton VaudN. Graf Clinical Trials Unit (CTU), Cantonal Hospital St Gallen – St Gallen P. Kohler Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen V. Musa Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen F. Grässli Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen M. Schlegel Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen S. Kessler Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen D. Flury
Speaker
Kantonsspital St. Gallen
|
P018
|
Nosocomial cluster of vancomycin resistant enterococci during COVID-19 pandemic
Poster flash presentation
SSHH
M. Van Singer
Speaker
Service of Hospital Preventive Medicine - Lausanne (Switzerland), Infectious Diseases Service, University Hospital of Lausanne and Lausanne University Hospital - Lausanne (Switzerland)D. Blanc Service of Hospital Preventive Medicine, University Hospital of Lausanne and Lausanne University Hospital - Lausanne (Switzerland)L. Senn Service of Hospital Preventive Medicine, University Hospital of Lausanne and Lausanne University Hospital - Lausanne (Switzerland)B. Grandbastien Service of Hospital Preventive Medicine, University Hospital of Lausanne and Lausanne University Hospital - Lausanne (Switzerland)
|
P019
|
Healthcare‑associated infections in COVID-19 and non-COVID-19 intensive care unit patients during the pandemic: a prospective surveillance study
Poster flash presentation
SSHH
S. Rüfenacht
Speaker
Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandM. Ludwinek Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandW. Frick Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandG. Kleger Division of Intensive Care, Cantonal Hospital St Gallen, St Gallen, SwitzerlandF. Schneider Division of Intensive Care, Cantonal Hospital St Gallen, St Gallen, SwitzerlandW. Albrich Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandD. Flury Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandS. Kuster Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandM. Schlegel Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandP. Kohler Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland
|
P020
|
Unraveling transmission clusters of SARS-CoV-2 in a tertiary academic care center
Poster flash presentation
SSHH
M. von Rotz
Speaker
University Hospital of BaselA. Durovic Swiss Tropical and Public Health InstituteS. Zingg University Hospital of BaselF. Banderet-Uglioni University Hospital of BaselA. Apitz University Hospital of BaselH. Seth-Smith University Hospital of BaselT. Roloff University Hospital of BaselS. Kuster University Hospital of BaselR. Kühl University Hospital of BaselA. Egli University Hospital of BaselS. Tschudin Sutter University Hospital of Basel
|
P021
|
Successful control of two distinct outbreaks of ESBL-producing Klebsiella species in a Paediatric Intensive Care Unit
Poster flash presentation
SSHH
A. Cusini
Speaker
Division of Infectious Diseases, Cantonal Hospital of Grisons, ChurU. Gadola Hospital Hygiene, Cantonal Hospital of Grisons, ChurS. Riess Hospital Hygiene, Cantonal Hospital of Grisons, ChurC. Guler Microbiology, Cantonal Hospital of Grisons, ChurC. Schumacher Department of Pediatrics, Cantonal Hospital of Grisons, ChurN. Binz Department of Pediatrics, Cantonal Hospital of Grisons, ChurH. Seth Smith Division of Clinical Bacteriology and Mycology, University Hospital BaselS. Seiffert Division of Human Microbiology, Centre for Laboratory Medicine, St. GallenF. Fleisch Division of Infectious Diseases, Cantonal Hospital of Grisons, ChurA. Egli Division of Clinical Bacteriology and Mycology, University Hospital Basel
|
P022
|
Outbreak of COVID-19 associated aspergillosis in an intensive care unit associated with construction work
Poster flash presentation
SSHH
G. Catho
Speaker
Hopital du Valais (RSV) - Institut Central (ICHV)E. Magualetti Institut Central des Hôpitaux (ICH) - Hopital Du ValaisC. Niggli Institut Central des Hôpitaux (ICH) - Hopital Du ValaisJ. Garcia Martinez Hopital du Valais (HVS) - Centre Hospitalier du Valais RomandX. Alvarez Hopital du Valais (HVS) - Centre Hospitalier du Valais RomandA. Milon Institut Central des Hôpitaux (ICH) - Hopital Du ValaisS. Emonet Institut Central des Hôpitaux (ICH) - Hopital Du Valais
|
P023
|
|
P024
|
|
P025
|
|
P026
|
Trained immunity provides durable protection against deadly sepsis
Poster
SSI
C. Gilbert
Speaker
CHUV Centre Hospitalier Universitaire Vaudois (CHUV)E. Ciarlo CHUV Centre Hospitalier Universitaire Vaudois (CHUV)T. Heinonen CHUV Centre Hospitalier Universitaire Vaudois (CHUV)C. Théroude CHUV Centre Hospitalier Universitaire Vaudois (CHUV)M. Reverte CHUV Centre Hospitalier Universitaire Vaudois (CHUV)D. Le Roy CHUV Centre Hospitalier Universitaire Vaudois (CHUV)T. Roger CHUV Centre Hospitalier Universitaire Vaudois (CHUV)
|
P027
|
B/F/TAF Five-Year Outcomes in Treatment-Naïve Adults
Poster
SSI
D. Wohl UNC School of MedicineA. Pozniak Chelsea and Westminster HospitalK. Workowski Emory UniversityD. Hagins Chatham County Health DepartmentE. Daar Lundquist Institute at Harbor-UCLA Medical CenterC. Orkin Barts Health NHS Trust, Royal London HospitalE. Koenig Instituto Dominicano de Estudios VirólgicosK. Mounzer Philadelphia FIGHT Community Health CentersS. Gupta Indiana University School of MedicineH. Huang Gilead Sciences, Inc.R. Acosta Gilead Sciences, Inc.J. Hindman Gilead Sciences, Inc.J. Baeten Gilead Sciences, Inc.H. Martin Gilead Sciences, Inc.T. Grabinger
Speaker
Gilead Sciences Switzerland SàrlP. Sax Brigham and Women’s Hospital, Harvard Medical School
|
P028
|
Quantification of within-patient Staphylococcus aureus phenotypic heterogeneity as a proxy for presence of persisters across clinical presentations
Poster
SSI
J. Bär
Speaker
University Hospital ZurichM. Boumasmoud University Hospital ZurichS. Mairpady Shambat University Hospital ZurichC. Vulin University Hospital ZurichM. Huemer University Hospital ZurichT. Schweizer University Hospital ZurichA. Gómez-Mejia University Hospital ZurichN. Eberhard University Hospital ZurichY. Achermann University Hospital ZurichP. Zingg Balgrist University HospitalC. Mestres University Hospital ZurichS. Brugger University Hospital ZurichR. Schuepbach University Hospital ZurichR. Kouyos University Hospital ZurichB. Hasse University Hospital ZurichA. Zinkernagel University Hospital Zurich
|
P029
|
|
P030
|
|
P031
|
|
P032
|
High Rates of Virologic Suppression With DTG/3TC in Newly Diagnosed Adults With HIV-1 Infection and Baseline Viral Load > 500,000 c/mL: 48-Week Subgroup Analysis of the STAT Study
Poster
SSI
C. Rolle Orlando Immunology Center, Orlando, FL, USAM. Berhe Baylor University Medical Center, Dallas, TX, USAT. Singh DAP Health, Palm Springs, CA, USAR. Ortiz Bliss Healthcare Services, Orlando, FL, USAA. Wurapa Infectious Disease Specialists of Atlanta, Decatur, GA, USAM. Ramgopal Midway Immunology and Research Center, Fort Pierce, FL, USAD. Jayaweera University of Miami Miller School of Medicine, Miami, FL, USAP. Leone ViiV Healthcare, Research Triangle Park, NC, USAJ. Matthews ViiV Healthcare, Research Triangle Park, NC, USAM. Cupo GlaxoSmithKline, Upper Providence, PA, USAM. Underwood ViiV Healthcare, Research Triangle Park, NC, USAK. Angelis GlaxoSmithKline, Brentford, UKC. Nguyen ViiV Healthcare, Research Triangle Park, NC, USAB. Wynne ViiV Healthcare, Research Triangle Park, NC, USAD. Merrill ViiV Healthcare, Research Triangle Park, NC, USAA. Bianchi
Speaker
ViiV HealthcareM. Mika ViiV Healthcare SwitzerlandJ. van Wyk ViiV Healthcare, Brentford, UKA. Zolopa ViiV Healthcare, Research Triangle Park, NC, USA and Stanford University, Palo Alto, CA, USA
|
P033
|
NT-proBNP cut-off as a prognostic marker towards one-year mortality in infective endocarditis
Poster
SSI
M. Padrutt
Speaker
Universitätsspital ZürichB. Ledergerber Universitätsspital ZürichM. Frank Universitätsspital ZürichJ. Epprecht Universitätsspital ZürichM. Greutmann Universitätsspital ZürichJ. Sromicki Universitätsspital ZürichR. Bauernschmitt Universitätsspital ZürichS. Brugger Universitätsspital ZürichA. Zinkernagel Universitätsspital ZürichB. Hasse Universitätsspital Zürich
|
P034
|
Effect of COVID-19 on hospitalizations for lower respiratory tract infections in Switzerland: comparison of national data between 2020 and 2015-2019
Poster
SSI
C. Bürke Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, SwitzerlandF. Baty Lung Center, Cantonal Hospital St. Gallen, St. Gallen, Switzerland F. Rassouli Lung Center, Cantonal Hospital St. Gallen, St. Gallen, Switzerland M. Brutsche Lung Center, Cantonal Hospital St. Gallen, St. Gallen, Switzerland W. Albrich
Speaker
Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
|
P035
|
Pulse oximetry as an aid to rule out pneumonia among patients with a lower respiratory tract infection in primary care
Poster
SSI
C. Fischer
Speaker
CHUV Centre Hospitalier Universitaire Vaudois (CHUV)J. Knusli CHUV Centre Hospitalier Universitaire Vaudois (CHUV)L. Lhopitallier Gare10 Lausanne General PracticeE. Tenisch CHUV Centre Hospitalier Universitaire Vaudois (CHUV)M. Meuwly CHUV Centre Hospitalier Universitaire Vaudois (CHUV)P. Douek CHUV Centre Hospitalier Universitaire Vaudois (CHUV)J. Meuwly CHUV Centre Hospitalier Universitaire Vaudois (CHUV)V. D’Acremont Centre for Primary Care and Public Health, University of LausanneA. Kronenberg IFIK Bern, mediX General Practice NetworkI. Locatelli Centre for Primary Care and Public Health, University of LausanneY. Mueller Centre for Primary Care and Public Health, University of LausanneN. Senn Centre for Primary Care and Public Health, University of LausanneN. Boillat-Blanco CHUV Centre Hospitalier Universitaire Vaudois (CHUV)
|
P036
|
|
P037
|
|
P038
|
IMPACT OF THE COVID-19 PANDEMIC ON INPATIENT ANTIBIOTIC CONSUMPTION IN SWITZERLAND
Poster
SSI
O. Friedli
Speaker
Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of BernM. Gasser Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of BernA. Cusini Cantonal Hospital GraubündenR. Fulchnini Infectious Diseases and Hospital Epidemiology, Thurgau Hospital Group, Muensterlingen and Frauenfeld, Switzerland.D. Vuichard-Gysin Infectious Diseases and Hospital Epidemiology, Thurgau Hospital Group, Muensterlingen and Frauenfeld, Switzerland.N. Wassilew Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.R. Halder Institute of Hospital Pharmacy, Bern University Hospital, University of Bern, SwitzerlandC. Plüss-Suard Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of Bern, Bern, Switzerland.A. Kronenberg Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
|
P039
|
|
P040
|
Overruling of procalcitonin guidance for lower respiratory tract infections in primary care: ancillary study of a randomized controlled trial
Poster
SSI
J. Knüsli
Speaker
Infectious Diseases Service of Lausanne University Hospital (CHUV)L. Lhopitallier gare10.chA. Kronenberg Institut für Infektionskrankheiten, Universität BernJ. Meuwly Department of Radiology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of LausanneO. Opota Microbiology Institute of Lausanne University Hospital (CHUV)M. Perrenoud Microbiology Institute of Lausanne University Hospital (CHUV)M. Page Microbiology Institute of Lausanne University Hospital (CHUV)K. Kain Tropical Disease Unit, Department of Medicine, University of TorontoA. Mamin Division of Infectious Diseases, University Hospital Geneva, University of Geneva, SwitzerlandV. D'Acremont Centre universitaire de médecine générale et santé publique - UnisantéN. Senn Centre universitaire de médecine générale et santé publique - UnisantéY. Mueller Centre universitaire de médecine générale et santé publique - UnisantéI. Locatelli Centre universitaire de médecine générale et santé publique - UnisantéN. Boillat-Blanco Infectious Diseases Service of Lausanne University Hospital (CHUV)
|
P041
|
Sex versus Gender-related Characteristics: Which Predicts Clinical Outcomes of Acute COVID-19?
Poster
SSI
A. Friedl
Speaker
Infectious Diseases & Hospital Epidemiology, Departement of Internal Medicine, Kantonsspital Baden, 54040 Baden, SwitzerlandC. Gebhard Intensive Care Unit, University Hospital Basel, Basel, SwitzerlandH. Nadia Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, SwitzerlandS. Bengs Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, SwitzerlandB. Gysi Intensive Care Unit, University Hospital Basel, Basel, SwitzerlandA. Dussault-Cloutier Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, SwitzerlandK. Buehler Institute of Intensive Care, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandR. Schuepbach Institute of Intensive Care, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandA. Zinkernagel Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandS. Brugger Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland C. Acevedo Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandD. Patriki Department of Internal Medicine, Cantonal Hospital of Baden, Baden, SwitzerlandB. Wiggli Infectious Diseases & Hospital Epidemiology, Departement of Internal Medicine, Kantonsspital Baden, 54040 Baden, SwitzerlandJ. Beer Department of Internal Medicine, Cantonal Hospital of Baden, Baden, SwitzerlandR. Twerenbold Department of Cardiology, University Hospital Basel, Basel, Switzerland and Department of Cardiology and University Center of Cardiovascular Science, University Heart and Vascular Center Hamburg, Hamburg, GermanyG. Kuster Department of Cardiology, University Hospital Basel, Basel, Switzerland and Department of Biomedicine, University of Basel, Basel, SwitzerlandH. Pargger Intensive Care Unit, University Hospital Basel Basel, Switzerland,S. Tschudin-Sutter Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel and University of Basel, Basel, SwitzerlandJ. Schefold Department of Intensive Care Medicine, Inselspital Bern University Hospital, University of Bern, Bern, SwitzerlandT. Spinetti Department of Intensive Care Medicine, Inselspital Bern University Hospital, University of Bern, Bern, SwitzerlandP. Wendel-Garcia Institute of Intensive Care, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandD. Hofmänner Institute of Intensive Care, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandT. Scheier Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandA. Todorov Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland and Center for Molecular Cardiology, University of Zurich, Schlieren, SwitzerlandH. Merdji Intensive Care Unit, University Hospital Basel, Basel, Switzerland M. Siegemund Intensive Care Unit, University Hospital Basel, Basel, Switzerland and University of Basel, Basel, SwitzerlandP. Gebert Institute of Biometry and Clinical Epidemiology, Charité – Universitätsmedizin Berlin, Berlin, GermanyV. Regitz-Zagrosek Charité, Universitätsmedizin Berlin, Germany and University of Zurich, Zurich, SwitzerlandC. Gebhard Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland and Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland
|
P042
|
Predictors of candidaemia mortality among critically-ill patients: a multicenter retrospective study
Poster
SSI
M. Papadimitriou-Olivgeris
Speaker
Lausanne University Hospital (CHUV)F. Fligou University General Hospital of PatrasF. Lamoth Lausanne University Hospital (CHUV)A. Spiliopoulou University General Hospital of PatrasJ. Pagani Lausanne University Hospital (CHUV)F. Kolonitsiou University General Hospital of PatrasA. Coste Lausanne University Hospital (CHUV)F. Paliogianni University General Hospital of PatrasM. Marangos University General Hospital of PatrasL. Senn Lausanne University Hospital (CHUV)
|
P043
|
Hormone intake differentially affects the immune system of HIV-positive cis and trans women
Poster
SSI
C. Pasin
Speaker
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and Institute of Medical Virology, University of Zurich, SwitzerlandD. Garcia Nuñez University Hospital BaselK. Kusejko University of ZurichA. Hachfeld University Hospital BernK. Aebi-Popp University Hospital BernH. Buvelot University Hospital GenevaM. Cavassini Lausanne University HospitalL. Damonti Regional Hospital LuganoC. Fux Kantonsspital AarauB. Martinez de Tejada University Hospital GenevaP. Vernazza Cantonal Hospital St. GallenA. Trkola Institute of Medical Virology, University of Zurich, SwitzerlandH. Günthard Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and Institute of Medical Virology, University of Zurich, SwitzerlandR. Kouyos Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and Institute of Medical Virology, University of Zurich, SwitzerlandI. Abela Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and Institute of Medical Virology, University of Zurich, Switzerland
|
P044
|
High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumosepsis and multi-organ failure
Poster
SSI
I. Schrijver CHUV Centre Hospitalier Universitaire Vaudois (CHUV)E. Karakike National and Kapodistrian University of AthensC. Gilbert
Speaker
CHUV Centre Hospitalier Universitaire Vaudois (CHUV)C. Théroude CHUV Centre Hospitalier Universitaire Vaudois (CHUV)P. Baumgartner CHUV Centre Hospitalier Universitaire Vaudois (CHUV)A. Harari CHUV Centre Hospitalier Universitaire Vaudois (CHUV)E. Giamarellos‑Bourboulis National and Kapodistrian University of AthensT. Calandra CHUV Centre Hospitalier Universitaire Vaudois (CHUV)T. Roger CHUV Centre Hospitalier Universitaire Vaudois (CHUV)
|
P045
|
Risk factors for incident active tuberculosis in HIV positive patients in the Swiss HIV Cohort Study
Poster
SSI
M. Zeeb
Speaker
Zurich University HospitalB. Tepekule Zurich University HospitalK. Kusejko Zurich University HospitalD. Braun Zurich University HospitalH. Günthard Zurich University HospitalJ. Notter St. Gallen Cantonal HospitalH. Furrer Insel University Hospital BerneM. Hoffmann Cantonal Hospital OltenH. Hirsch Basel University HospitalA. Calmy Geneva University HospitalM. Cavassini Lausanne University HospitalM. Battegay Basel University HospitalE. Bernasconi Regional Hospital LuganoR. Kouyos Zurich University HospitalJ. Nemeth Zurich University Hospital
|
P046
|
Long-acting cabotegravir + rilpivirine every 2 months: week 152 phase 3 randomized clinical trial results
Poster
SSI
E. Overton University of Alabama at Birmingham, Birmingham, AL, United StatesG. Richmond Nova Southeastern University, FL, United StatesG. Rizzardini Department of Infectious Diseases, Fatebenefratelli Sacco Hospital, Milan, Italy & School of Clinical Medicine, Faculty of Health Science University of the Witwatersrand, Johannesburg, South AfricaA. Thalme Department of Infectious Diseases, Karolinska University Hospital, Stockholm, SwedenP. Girard Department of Infectious and Tropical Diseases & Inserm, University of Paris, St Antoine Hospital, Paris, FranceA. Wong University of Saskatchewan, Regina, CanadaN. Porteiro Fundacion IDEAA, Buenos Aires, ArgentinaC. Español GlaxoSmithKline, Brentford, United KingdomC. Acuipil GlaxoSmithKline, Buenos Aires, ArgentinaA. Aksar GlaxoSmithKline, Manchester, United KingdomY. Wang GlaxoSmithKline, Collegeville, PA, United StatesR. D’Amico ViiV Healthcare, Research Triangle Park, NC, United StatesC. Talarico ViiV Healthcare, Research Triangle Park, NC, United StatesK. Vandermeulen Janssen Research & Development, Beerse, BelgiumP. Rhein
Speaker
ViiV Healthcare, Münchenbuchsee, SwitzerlandW. Spreen ViiV Healthcare, Research Triangle Park, NC, United States
|
P047
|
TREATMENT WITH BULEVIRTIDE IMPROVES PATIENT REPORTED OUTCOMES IN PATIENTS WITH CHRONIC HEPATITIS DELTA (CHD): AN INTERIM EXPLORATORY ANALYSIS AT WEEK 24
Poster
SSI
C. Oberle
Speaker
Gilead Sciences Switzerland SàrlH. Wedemeyer Medizinische Hochschule HannoverS. Aleman Karolinska Universitetssjukhuset, Karolinska lnstitutetV. Chulanov Central Research Institute of EpidemiologyG. Hilgard Universitatsklinikum EssenJ. Antonova Gilead Sciences, Inc.A. Kaushik Gilead Sciences, Inc.A. Lloyd Acaster Lloyd Consulting LtdD. Manuilov Gilead Sciences, Inc.V. Suri Gilead Sciences, Inc.T. Tran Gilead Sciences, Inc.A. Osinusi Gilead Sciences, Inc.P. Lampertico Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, CRC “a.M. and a. Migliavacca” Center for Liver Disease, Universita Degli Studi Di MilanoV. Morozov Hepatolog, LLCO. Sagalova Southern Ural State Medical UniversityT. Stepanova Clinic of Modern MedicineM. Buti Hospital Universitario Valle Hebron
|
P048
|
Initiating long-acting cabotegravir and rilpivirine in a real-world setting – clinical characteristics and switch reasons from PLHIV and healthcare provider perspective in the German CARLOS cohort
Poster
SSI
C. Wyen Praxis Ebertplatz, Cologne, GermanyJ. Scherzer ViiV Healthcare, Munich, GermanyC. Oldenbüttel MVZ München am Goetheplatz, Munich, GermanyC. Lieb Praxis Goldstein, Berlin, GermanyK. Ummard-Berger 5UBN / Praxis, Berlin, GermanyC. Cordes Praxis Dr. Cordes, Berlin, GermanyN. Postel prinzmed, Munich, GermanyS. Dakhia ViiV Healthcare, Brentford, London UKB. Westermayer GlaxoSmithKline, Munich, GermanyT. Edinger
Speaker
ViiV Healthcare, Münchenbuchsee, SwitzerlandK. Bernhardt ViiV Healthcare, Munich, Germany
|
P049
|
Long-Acting Lenacapavir in People With Multidrug-Resistant HIV-1: Week 52 Results
Poster
SSI
O. Ogbuagu Yale University School of MedicineS. Segal-Maurer New York Presbyterian QueensC. Brinson Central Texas Clinical ResearchP. Chetchotisakd Srinagarind HospitalK. Workowski Emory UniversityJ. McGowan North Shore University HospitalH. Wang Gilead Sciences, Inc.N. Margot Gilead Sciences, Inc.H. Dvory-Sobol Gilead Sciences, Inc.M. Rhee Gilead Sciences, Inc.J. Baeten Gilead Sciences, Inc.T. Grabinger
Speaker
Gilead Sciences Switzerland SàrlJ. Molina Hopital Saint Louis
|
P050
|
Behavioral and immune parameters steer susceptibility to SARS-CoV-2 infection in People with HIV in the SWISS HIV Cohort Study (SHCS)
Poster
SSI
R. Kouyos
Speaker
University Hospital and University of Zurich, Zurich, SwitzerlandI. Abela University Hospital and University of Zurich, Zurich, SwitzerlandA. Hauser University Hospital and University of Zurich, Zurich, SwitzerlandM. Schwarzmüller University of ZurichC. Pasin University Hospital and University of Zurich, Zurich, SwitzerlandS. Epp University of ZurichM. Cavassini Lausanne University HospitalM. Battegay University Hospital BaselA. Rauch Bern University HospitalA. Calmy Geneva University HospitalJ. Notter Cantonal Hospital St. GallenE. Bernasconi Regional Hospital LuganoC. Fux Kantonsspital AarauK. Leuzinger University of BaselM. Perreau Lausanne University HospitalA. Ramette University of BernS. Yerly Geneva University HospitalJ. Gottschalk Blood Transfusion Service ZurichE. Schindler Blood Transfusion Service ZurichA. Wolfensberger University Hospital ZurichS. Rampini University Hospital ZurichA. Wepf Cantonal Hospital WinterthurU. Karrer Cantonal Hospital WinterthurM. Marconato University Hospital ZurichM. Manz University Hospital ZurichB. Frey Blood Transfusion Service ZurichD. Braun University Hospital ZurichM. Huber University of ZurichH. Günthard University Hospital and University of Zurich, Zurich, SwitzerlandA. Trkola University of Zurich
|
P051
|
Mortality and morbidity related to the Hepatitis C Virus: a propensity score matching analysis using routinely collected data from a large, tertiary hospital in Switzerland
Poster
SSI
F. Hovaguimian (Lachmann)
Speaker
Division of Infectious Disease and Hospital Epidemiology; University Hospital of Zurich and University of ZurichP. Beeler Division of Occupational and Environmental Medicine; Epidemiology, Biostatistics and Prevention Institute, University of Zurich and University Hospital ZurichB. Müllhaupt Department of Gastroenterology and Hepatology, University Hospital of ZurichH. Günthard Division of Infectious Disease and Hospital Epidemiology; University Hospital of Zurich and University of ZurichB. Maeschli Swiss HepatitisP. Bruggmann Arud Centers for Addiction MedicineJ. Fehr Department of Public and Global Health, Epidemiology, Biostatistics and Prevention Institute, University of ZurichR. Kouyos Division of Infectious Disease and Hospital Epidemiology; University Hospital of Zurich and University of Zurich
|
P052
|
|
P053
|
|
P054
|
|
P055
|
Trends and outcomes of patients hospitalized with COVID-19 during the first and second wave: A nationwide cohort study
Poster
SSI
C. Gregoriano
Speaker
Cantonal Hospital Aarau, Aarau, SwitzerlandK. Rafaisz Cantonal Hospital Aarau, Aarau, Switzerland; University of BaselP. SCHUETZ Cantonal Hospital Aarau, Aarau, Switzerland; University of BaselB. Mueller Cantonal Hospital Aarau, Aarau, Switzerland; University of BaselC. Fux Cantonal Hospital Aarau, Aarau, SwitzerlandA. Conen Cantonal Hospital Aarau, Aarau, SwitzerlandA. Kutz Cantonal Hospital Aarau, Aarau, Switzerland; Brigham and Women's Hospital and Harvard Medical School
|
P056
|
|
P057
|
|
P058
|
Bulevirtide monotherapy at low and high dose in patients with chronic hepatitis delta: 24-week interim data of the Phase 3 MYR301 study
Poster
SSI
C. Oberle
Speaker
Gilead Sciences Switzerland SàrlH. Wedemeyer Medizinische Hochschule HannoverS. Aleman Karolinska University Hospital/Karolinska InstitutetM. Brunetto University Hospital of Pisa and Department of Clinical and Experimental MedicineA. Blank Heidelberg University HospitalP. Andreone University of Modena and Reggio EmiliaP. Bogomolov State Budgetary Institution of Health Care of Moscow region “Moscow Regional Research Clinical Institute after M.F. Vladimirsky"V. Chulanov FSBI National Research Medical Center for Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian FederationN. Mamonova FSBI National Research Medical Center for Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian FederationN. Geyvandova Stavropol Regional HospitalV. Morozov LLC Medical Company “Hepatolog” O. Sagalova Federal state-funded institution of higher education "Southern Ural State Medical University of Ministry of Health of the Russian Federation"T. Stepanova LLC “Clinic of Modern Medicine"D. Manuilov Gilead Sciences, Inc.V. Suri Gilead Sciences, Inc.Q. An Gilead Sciences, Inc.J. Flaherty Gilead Sciences, Inc.A. Osinusi Gilead Sciences, Inc.J. Schulze zur Wiesch Universitätsklinikum Hamburg-Eppendorf Medizinische Klinik Studienambulanz HepatologieM. Cornberg Medizinische Hochschule HannoverS. Zeuzem University Hospital FrankfurtP. Lampertico Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico & CRC “A. M. and A. Migliavacca” Center for Liver Disease, University of Milan
|
P059
|
|
P060
|
A qualitative exploration of HIV stigma and its impact on accessing healthcare
Poster
SSI
D. Jackson-Perry Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)C. Le Saux
Speaker
Centre universitaire de médecine générale et santé publique - UnisantéI. Gilles Centre universitaire de médecine générale et santé publique - UnisantéC. Storari Centre universitaire de médecine générale et santé publique - UnisantéO. Keserue Pittet Centre universitaire de médecine générale et santé publique - UnisantéO. Nawej Tshikung HUG Hôpitaux Universitaires GenèveE. Cart Centre universitaire de médecine générale et santé publique - UnisantéM. Cavassini Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)K. Darling Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)
|
P061
|
|
P062
|
Intensified screening for chronic hepatitis B in Macenta, Republic of Guinea: a prospective cohort study
Poster
SSI
C. Henzen
Speaker
Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandJ. Hebelamou Centre Hospitalier Régional Spécialisé, Macenta, GuineaY. Guilavogui Centre Hospitalier Régional Spécialisé, Macenta, GuineaA. Rauch Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandS. Onivogui Centre Hospitalier Régional Spécialisé, Macenta, GuineaC. Fux Department of Infectious Diseases, Kantonsspital Aarau, Aarau, SwitzerlandM. Seydi Centre Hospitalier National Universitaire (CHNU) Fann, Dakar, SenegalC. Staehelin Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandD. Leuenberger Department of Infectious Diseases, Kantonsspital Aarau, Aarau, Switzerland
|
P063
|
|
P064
|
Clinical presentation and disease course of clinical pneumonia in primary care according to microbiological etiology: ancillary study of a randomized controlled trial
Poster
SSI
J. Knüsli
Speaker
Infectious Diseases Service of Lausanne University Hospital (CHUV)L. Lhopitallier gare10.chA. Kronenberg Institut für Infektionskrankheiten, Universität BernJ. Meuwly Department of Radiology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of LausanneO. Opota Microbiology Institute of Lausanne University Hospital (CHUV)M. Perrenoud Microbiology Institute of Lausanne University Hospital (CHUV)M. Page Microbiology Institute of Lausanne University Hospital (CHUV)A. Mamin Division of Infectious Diseases, University Hospital Geneva, University of Geneva, SwitzerlandV. D'Acremont Centre universitaire de médecine générale et santé publique - UnisantéI. Locatelli Centre universitaire de médecine générale et santé publique - UnisantéN. Senn Centre universitaire de médecine générale et santé publique - UnisantéY. Mueller Centre universitaire de médecine générale et santé publique - UnisantéN. Boillat-Blanco Infectious Diseases Service of Lausanne University Hospital (CHUV)
|
P065
|
|
P066
|
|
P067
|
|
P068
|
Archived Resistance and Response to < 40 c/mL and TND: DTG/3TC FDC at Week 48 in SALSA
Poster
SSI
M. Underwood ViiV Healthcare, Research Triangle Park, NCO. Osiyemi Triple O Research Institute PA, West Palm Beach, FL, USR. Rubio Department of Internal Medicine, Hospital Universitario 12 de Octubre, UCM, Madrid, SpainL. Hocqueloux 4Centre Hospitalier Régional d’Orléans, Orléans, FranceN. Porteiro Fundacion IDEAA, Buenos Aires, ArgentinaO. Degen Universitätsklinikum Hamburg-Eppendorf, Hamburg, GermanyJ. Oyee GlaxoSmithKline, Brentford, UKJ. Horton Parexel International, Durham, NC, USAC. Parry ViiV Healthcare, Brentford, UKR. Wang ViiV Healthcare, Research Triangle Park, NC, USAM. Sithamparanathan ViiV Healthcare, Brentford, UKJ. van Wyk ViiV Healthcare, Brentford, UKB. Wynne ViiV Healthcare, Research Triangle Park, NC, USAC. Man ViiV Healthcare, Research Triangle Park, NC, USAM. Mika
Speaker
ViiV Healthcare SwitzerlandE. Blair ViiV Healthcare, Research Triangle Park, NC, USA
|
P069
|
|
P070
|
Clinical and imaging features of COVID-19 associated pulmo-nary aspergillosis
Poster
SSI
T. Fischer Cantonal Hospital, St. GallenY. El Baz Cantonal Hospital St. GallenN. Graf St. Gallen Cantonal HospitalS. Wildermuth St. Gallen Cantonal HospitalS. Leschka St. Gallen Cantonal HospitalG. Kleger St. Gallen Cantonal HospitalU. Pietsch St. Gallen Cantonal HospitalM. Frischknecht St. Gallen Cantonal HospitalG. Scanferla St. Gallen Cantonal HospitalC. Strahm St. Gallen Cantonal HospitalS. Wälti St. Gallen Cantonal HospitalT. Dietrich St. Gallen Cantonal HospitalW. Albrich
Speaker
Kantonsspital St.Gallen
|
P071
|
Systematic Review and Meta-Analysis of Integrated Studies on Salmonella and Campylobacter Prevalence, Serovar, and Phenotyping and Genetic of Antimicrobial Resistance in the Middle East—A One Health Perspective
Poster
SSI
S. Abukhattab
Speaker
Swiss Tropcial and Public Health Institute Basel & University of Basel, Basel, SwitzerlandH. Taweel Birzeit UniversityA. Awad Birzeit UniversityL. Crump Swiss Tropcial and Public Health Institute Basel & University of Basel, Basel, SwitzerlandP. Vonaesch University of Lausanne (UNIL), Faculty of Biology and Medicine, Lausanne, Switzerland.J. Zinsstag Swiss Tropical and Public Health Institute & University of Basel, Basel, SwitzerlandJ. Hattendorf Swiss Tropical and Public Health Institute & University of Basel, Basel, SwitzerlandN. Abu-Rmeileh Birzeit University
|
P072
|
|
P073
|
Combining antibiotics to curb antibiotic resistance: A systematic review and meta-analysis
Poster
SSI
B. Siedentop
Speaker
Institute of Integrative Biology, ETH Zurich, Zurich, SwitzerlandV. Kachalov Health Geography and Policy Group, ETH Zurich, Zurich, Switzerland C. Witzany Institute of Integrative Biology, ETH Zurich, Zurich, SwitzerlandA. Hauser Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, SwitzerlandM. Egger Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland R. Kouyos Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, SwitzerlandS. Bonhoeffer Institute of Integrative Biology, ETH Zurich, Zurich, Switzerland
|
P074 (O04)
|
|
P075 (O04)
|
|
P076 (O04)
|
|
P077 (O04)
|
|
P078
|
|
P079
|
Increased hand hygiene adherence in hospitals during high SARS-CoV-2 activity – data from a Swiss national surveillance system
Poster
SSHH
S. Rüfenacht
Speaker
Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandP. Kohler Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandR. Kuhn Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandD. Flury Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandA. Widmer Swissnoso, Swiss Centre for Infection Prevention, Bern, SwitzerlandM. Schlegel Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland
|
P080
|
|
P081
|
Das Phantom des Bacillus cereus
Poster
SSHH
M. Meier
Speaker
UniversitätsSpital Zürich (USZ)A. Wolfensberger UniversitätsSpital Zürich (USZ)J. Fontijn UniversitätsSpital Zürich (USZ)M. Bryant UniversitätsSpital ZürichB. Chakrakodi UniversitätsSpital Zürich (USZ)B. Duvnjak UniversitätsSpital Zürich (USZ)A. Frey Zuger Kantonsspital AGW. Zingg UniversitätsSpital Zürich (USZ)
|
P082
|
|
P083
|
Report of the first nosocomial outbreak of vancomycin-resistant Enterococcus faecium (VRE) ST796 in Europe
Poster
SSHH
V. Piezzi
Speaker
Inselspital, University Hospital BernN. Wassilew Inselspital, University Hospital BernA. Atkinson Inselspital, University Hospital BernS. D'Incau Lucerne Cantonal HospitalT. Kaspar Inselspital, University Hospital BernH. Seth-Smith University and University Hospital BaselC. Casanova Institute for Infectious Diseases, University of BernP. Bittel Institute for Infectious Diseases, University of BernP. Jent Inselspital, University Hospital BernR. Sommerstein Inselspital, University Hospital BernN. Buetti Geneva University Hospitals and Faculty of MedicineJ. Marschall Washington University School of Medicine
|
P084
|
|
P085
|
|
P086
|
Outbreak of nosocomial parainfluenza 3 in a nursing home while relaxing COVID-19 measures
Poster
SSHH
C. Schuttel
Speaker
Institut Central des Hôpitaux (ICH) - Hopital Du ValaisP. Beck Institut Central des Hôpitaux (ICH) - Hopital Du ValaisJ. Ferreira Nuring home Le CarillonR. Genoud Nuring home Le CarillonS. Oggier Nuring home Le CarillonE. May Institut Central des Hôpitaux (ICH) - Hopital Du ValaisF. Bally Institut Central des Hôpitaux (ICH) - Hopital Du ValaisG. Catho Institut Central des Hôpitaux (ICH) - Hopital Du Valais
|
P087
|
|
P088
|
Risk factors for postoperative infection in colorectal surgery
Poster
SSHH
N. Bloch
Speaker
Kantonsspital St GallenR. Kuhn Kantonsspital St GallenW. Brunner Kantonsspital St. GallenS. Kuster Kantonsspital St GallenD. Flury Kantonsspital St GallenM. Schlegel Kantonsspital St GallenP. Kohler Kantonsspital St Gallen
|
P089
|
Adherence with infection prevention guidelines during the COVID-19 pandemic in long-term care facilities: data from a multicentre cohort from Eastern and Western Switzerland.
Poster
SSHH
G. Scanferla Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen D. Hequet Unité cantonale hygiène, prévention et contrôle de l’infection, Canton VaudN. Graf Clinical Trials Unit (CTU), Cantonal Hospital St Gallen – St Gallen (Switzerland)F. Grässli Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen V. Musa Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen M. Schlegel Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen S. Kessler Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen D. Flury
Speaker
Department of Infectious Diseases/Hospital Epidemiology, Cantonal Hospital St Gallen – St Gallen
|
P090
|
surveillance des infections en dialyse : expérience du CHUV
Poster
SSHH
a. Lacot
Speaker
service de maladies infectieuses, CHUV Centre hospitalier universitaire vaudoisM. Pruijm service de néphrologie, CHUV Centre hospitalier universitaire vaudoisS. Kissling service de néphrologie, CHUV Centre hospitalier universitaire vaudoisA. Vital-Heilbronn service de maladies infectieuses, CHUV Centre hospitalier universitaire vaudoisI. Federli-Hanachi service de maladies infectieuses, CHUV Centre hospitalier universitaire vaudoisL. Senn service de maladies infectieuses, CHUV Centre hospitalier universitaire vaudoisB. Grandbastien service de maladies infectieuses, CHUV Centre hospitalier universitaire vaudois
|
P091
|
Parallel dynamics in the yield of universal SARS-CoV-2 admission screening and population incidence
Poster
SSHH
P. Schreiber
Speaker
University Hospital Zurich and University of Zurich, SwitzerlandT. Scheier University Hospital Zurich and University of Zurich, SwitzerlandA. Wolfensberger University Hospital Zurich and University of Zurich, SwitzerlandD. Saleschus University Hospital Zurich and University of Zurich, SwitzerlandM. Vazquez University Hospital Zurich and University of Zurich, SwitzerlandR. Kouyos University Hospital Zurich and University of Zurich, SwitzerlandW. Zingg University Hospital Zurich and University of Zurich, Switzerland
|
P092
|
Fallbericht einer Legionellose in der SARS CoV2 Pandemie
Poster
SSHH
B. Müller-Steiert
Speaker
Bürgerspital SolothurnM. Schärer Klinik für Infektiologie und Spitalhygiene der Solothurner Spitäler AGR. Piso Kantonsspital OltenB. Dübi Kantonsärztlicher Dienst SolothurnM. Hoffmann Kantonsspital Olten
|
P093
|
|
P094
|
|
P095
|
|
P096
|
|
P097
|
|
P098
|
|
P099
|
|
P100
|
|